Skip to main content

DNL

ETF
—
—

Performance overview

DNL Price
Price Chart

Forward-looking statistics

Beta
0.66
Risk
15.04%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Fund Profile

—

Fund info

—

Investing methodPassively Managed
DiversifiedYes
Expense ratio0.58%
Asset classUnknown

Company info

Sector—
Industry—
Website—
AUM—

Security info

ExchangeNyse American
Type of shareN/A
Earnings per share (EPS)—
Dividend per share$0.46
Revenue per share—
Avg trading volume (30 day)$1M
Avg trading volume (10 day)$1M
Put-call ratioN/A

Macro factor sensitivity

Growth-0.4
Credit+3.1
Liquidity-0.1
Inflation-2.1
Commodities-0.4
Interest Rates-1.4

Upcoming events

Next earnings day—
Next dividend day—
Ex. dividend dayMarch 26, 2025

News

DNLI's BLA for Hunter Syndrome Drug Gets FDA's Priority Review

Denali's lead drug for Hunter syndrome wins FDA Priority Review, marking a key step toward commercial-stage status.

Zacks Investment Research (July 8, 2025)
Is WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) a Strong ETF Right Now?

Launched on 06/16/2006, the WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) is a smart beta exchange traded fund offering broad exposure to the World ETFs category of the market.

Zacks Investment Research (May 29, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free